quinuclidines has been researched along with Colorectal Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Cheng, X; Fu, C; Hong, X; Kang, J; Ma, J; Meng, Y; Shao, G; Shi, Y; Wang, L; Wang, X; Wang, Y; Yan, Z; Zhang, Q | 1 |
| Chan, ZL; Chen, ZR; Chng, WJ; Chooi, JY; Li, XL; Zhou, J | 1 |
| Duan, Q; Lu, T; Potter, JA; Qiu, H; Taylor, GL; Wang, Y; Xiong, H; Xu, G; Yang, Q; Ye, D; Yu, S; Yuan, X; Zhang, P; Zhu, F; Zou, Y | 1 |
| Hayakawa, Y; Muro, K; Noma, H; Okamoto, H; Sato, Y; Tatematsu, M | 1 |
4 other study(ies) available for quinuclidines and Colorectal Cancer
| Article | Year |
|---|---|
A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aprepitant; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Extracellular Signal-Regulated MAP Kinases; Humans; Mice; Mice, Nude; Neurokinin-1 Receptor Antagonists; Piperidines; Proto-Oncogene Proteins c-myc; Quinuclidines; Signal Transduction; Survival Rate; Transplantation, Heterologous | 2021 |
PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms.
Topics: Animals; Caco-2 Cells; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; HT29 Cells; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Quinuclidines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; HCT116 Cells; HT29 Cells; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase Kinases; Mice, Nude; Molecular Docking Simulation; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Quinuclidines; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
[Antiemetic effect of palonosetron in advanced colorectal cancer patients receiving mFOLFOX6 and FOLFIRI: a retrospective survey].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Isoquinolines; Leucovorin; Male; Middle Aged; Nausea; Organoplatinum Compounds; Palonosetron; Quinuclidines; Retrospective Studies; Vomiting | 2012 |